http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2022204026-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cddff00c2cb6f641f798b0495ff35828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6e9a651703697882190f53183e12ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e92e7f061af4c8eb2c02726437eb1fea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7793940bc171b97e2de6279e8c1b53e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ee9d3b028c70aa2ff2f41112bae994f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976d7dae48f40df24063e0ca851b8524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf993f536dacc657e8c7026bf7f5445f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca7115bf299b76bf1f5a935fd68c201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_350c9d4b3f2fb43e86096f92e6e132b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4362ab85e8d17b0008af424de23eb075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871c714d496fd48c95822e181e57ee5d
publicationDate 2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2022204026-A1
titleOfInvention Benzisothiazole, isothiazolo[3,4-b]pyridine, quinazoline, phthalazine, pyrido[2,3-d]pyridazine and pyrido[2,3-d]pyrimidine derivatives as KRAS G12C inhibitors for treating lung, pancreatic or colorectal cancer
abstract BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-BIPYRIDINE, QUINAZOLINE, nPHTHALAZINE, PYRIDO[2,3-DIPYRIDAZINE AND PYRIDO[2,3-DIPYRIMIDINE nDERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC nOR COLORECTAL CANCER nABSTRACT nProvided herein are KRAS G12C inhibitors, composition of the same and methods of using the nsame. These inhibitors are useful for treating a number of disorders, including pancreatic, ncolorectal, and lung cancers.
priorityDate 2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426247440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21832354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410792880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415736805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414864976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468

Total number of triples: 68.